Viewing Study NCT06680258

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 12:16 AM
Ignite Modification Date: 2026-02-22 @ 7:24 AM
Study NCT ID: NCT06680258
Status: NOT_YET_RECRUITING
Last Update Posted: 2025-09-03
First Post: 2024-11-04
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: A Study of TPST-1120 With Atezolizumab Plus Bevacizumab in Patients With Unresectable or Metastatic HCC Not Previously Treated With Systemic Therapy
Sponsor: Tempest Therapeutics
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Hepatocellular Carcinoma (HCC) View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Hepatocellular carcinoma View
None liver cancer View
None metastatic View
None atezolizumab View
None bevacizumab View
None advanced View
None unresectable View
None PD-L1 View
None b-catenin View
None CTNNB1 View